Arian Lasocki

1.3k total citations
60 papers, 841 citations indexed

About

Arian Lasocki is a scholar working on Genetics, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Arian Lasocki has authored 60 papers receiving a total of 841 indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Genetics, 24 papers in Radiology, Nuclear Medicine and Imaging and 19 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Arian Lasocki's work include Glioma Diagnosis and Treatment (40 papers), Radiomics and Machine Learning in Medical Imaging (17 papers) and Brain Metastases and Treatment (15 papers). Arian Lasocki is often cited by papers focused on Glioma Diagnosis and Treatment (40 papers), Radiomics and Machine Learning in Medical Imaging (17 papers) and Brain Metastases and Treatment (15 papers). Arian Lasocki collaborates with scholars based in Australia, United States and United Kingdom. Arian Lasocki's co-authors include Frank Gaillard, Katharine J. Drummond, Mark Tacey, Stephen Stuckey, Alexandra Gorelik, Michael Gonzales, Abhishta Bhandari, Simon J. Harrison, Stefanie Thust and Alpha Tsui and has published in prestigious journals such as American Journal of Neuroradiology, Radiotherapy and Oncology and European Journal of Nuclear Medicine and Molecular Imaging.

In The Last Decade

Arian Lasocki

55 papers receiving 830 citations

Peers

Arian Lasocki
Sied Kebir Germany
Matthew M. Grabowski United States
Axel Siefert Germany
Shyam Tanguturi United States
Reena Thomas United States
Garry Ceccon Germany
Arian Lasocki
Citations per year, relative to Arian Lasocki Arian Lasocki (= 1×) peers Jan‐Michael Werner

Countries citing papers authored by Arian Lasocki

Since Specialization
Citations

This map shows the geographic impact of Arian Lasocki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arian Lasocki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arian Lasocki more than expected).

Fields of papers citing papers by Arian Lasocki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arian Lasocki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arian Lasocki. The network helps show where Arian Lasocki may publish in the future.

Co-authorship network of co-authors of Arian Lasocki

This figure shows the co-authorship network connecting the top 25 collaborators of Arian Lasocki. A scholar is included among the top collaborators of Arian Lasocki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arian Lasocki. Arian Lasocki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lasocki, Arian, et al.. (2026). The role of neuroimaging in neurotoxicity after chimeric antigen receptor T-cell therapy. Therapeutic Advances in Neurological Disorders. 19. 4243685552–4243685552.
2.
Lasocki, Arian, et al.. (2025). Standardisation of the radiological definition of supramaximal resection in glioblastoma. Journal of Clinical Neuroscience. 133. 111037–111037.
3.
Lasocki, Arian, Joseph Sia, & Stephen Stuckey. (2025). Differentiation Between Radiation Necrosis and True Tumour Progression After Radiotherapy to Intracranial Metastases. Journal of Medical Imaging and Radiation Oncology. 69(3). 414–424. 4 indexed citations
4.
Lasocki, Arian, et al.. (2023). Prospective Comparison of T1-SPACE and MPRAGE for the Identification of Intrinsic T1 Hyperintensity in Patients with Intracranial Melanoma Metastases. American Journal of Neuroradiology. 44(9). 1039–1044. 1 indexed citations
5.
Lasocki, Arian, et al.. (2023). Radiogenomics Provides Insights into Gliomas Demonstrating Single-Arm 1p or 19q Deletion. American Journal of Neuroradiology. 44(11). 1270–1274. 1 indexed citations
6.
Lasocki, Arian, Michael E. Buckland, Jing Xie, et al.. (2023). Correlating MRI features with additional genetic markers and patient survival in histological grade 2-3 IDH-mutant astrocytomas. Neuroradiology. 65(8). 1215–1223. 8 indexed citations
7.
Hamilton, Daniel G., et al.. (2023). Radiation necrosis and therapeutic outcomes in patients treated with linear accelerator‐based hypofractionated stereotactic radiosurgery for intact intracranial metastases. Journal of Medical Imaging and Radiation Oncology. 67(3). 308–319. 1 indexed citations
8.
10.
Iravani, Amir, Arian Lasocki, Roslyn Wallace, et al.. (2023). Imaging for assessment of cancer treatment response to immune checkpoint inhibitors can be complementary in identifying hypophysitis. Frontiers in Endocrinology. 14. 1295865–1295865. 4 indexed citations
11.
Lasocki, Arian, et al.. (2023). Radiogenomics of adult intracranial gliomas after the 2021 World Health Organisation classification: a review of changes, challenges and opportunities. Quantitative Imaging in Medicine and Surgery. 13(11). 7572–7581. 1 indexed citations
12.
Lasocki, Arian, Michael E. Buckland, Katharine J. Drummond, et al.. (2022). Conventional MRI features can predict the molecular subtype of adult grade 2–3 intracranial diffuse gliomas. Neuroradiology. 64(12). 2295–2305. 18 indexed citations
13.
14.
Iravani, Amir, Medhat Osman, Alison M. Weppler, et al.. (2020). FDG PET/CT for tumoral and systemic immune response monitoring of advanced melanoma during first-line combination ipilimumab and nivolumab treatment. European Journal of Nuclear Medicine and Molecular Imaging. 47(12). 2776–2786. 49 indexed citations
15.
Lasocki, Arian & Kortnye Smith. (2020). Autoimmune polyradiculitis due to combination immunotherapy with ipilimumab and nivolumab for the treatment of metastatic melanoma. Journal of Clinical Neuroscience. 74. 240–241. 6 indexed citations
16.
Lasocki, Arian & Frank Gaillard. (2019). Non-Contrast-Enhancing Tumor: A New Frontier in Glioblastoma Research. American Journal of Neuroradiology. 40(5). 758–765. 97 indexed citations
17.
Lasocki, Arian, Frank Gaillard, Alexandra Gorelik, & Michael Gonzales. (2018). MRI Features Can Predict 1p/19q Status in Intracranial Gliomas. American Journal of Neuroradiology. 39(4). 687–692. 81 indexed citations
18.
Lasocki, Arian, Frank Gaillard, Mark Tacey, Katharine J. Drummond, & Stephen Stuckey. (2016). The incidence and significance of multicentric noncontrast-enhancing lesions distant from a histologically-proven glioblastoma. Journal of Neuro-Oncology. 129(3). 471–478. 16 indexed citations
19.
Lasocki, Arian, Frank Gaillard, Mark Tacey, Katharine J. Drummond, & Stephen Stuckey. (2016). Multifocal and multicentric glioblastoma: Improved characterisation with FLAIR imaging and prognostic implications. Journal of Clinical Neuroscience. 31. 92–98. 43 indexed citations
20.
Lasocki, Arian, Frank Gaillard, Mark Tacey, Katharine J. Drummond, & Stephen Stuckey. (2015). Incidence and prognostic significance of non‐enhancing cortical signal abnormality in glioblastoma. Journal of Medical Imaging and Radiation Oncology. 60(1). 66–73. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026